Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05162079
Other study ID # SEFAC1.20I.
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date March 1, 2022
Est. completion date September 1, 2022

Study information

Verified date December 2021
Source Universidad Miguel Hernandez de Elche
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Introduction: Symptoms as heartburn and/or reflux is frequent consultations in community pharmacies, the characterization of them is crucial to provide appropriate patient counseling. To facilitate the assistance work of the community pharmacist and its coordination between different levels of care, a group of experts in Community Pharmacy, Primary Care, and Gastroenterology has recently worked on an algorithm to manage these symptoms. Objective: Analyse the epidemiological characteristics of patients who consult for symptoms of heartburn and/or reflux in Spanish community pharmacies, and evaluate the clinical and humanistic results of the protocolization of a Professional Pharmaceutical Service in said patients. Methods and analysis: The study design consists of a cross-sectional descriptive part, in which the clinical and sociodemographic characteristics of the patients who come to the community pharmacy will be evaluated for consultation derived from heartburn and/or reflux symptoms and a before-after descriptive study in which will evaluate the clinical and humanistic results in patients who come to the pharmacy after receiving pharmaceutical care.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1200
Est. completion date September 1, 2022
Est. primary completion date July 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Population´s age = 18 years - Patients who consult for mild symptoms of heartburn and/or gastroesophageal reflux or request treatment for it. Exclusion Criteria: - Subjects who request treatment for symptoms of heartburn and/or gastroesophageal reflux for another person - Women with high-risk pregnancies

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universidad Miguel Hernandez de Elche

Outcome

Type Measure Description Time frame Safety issue
Primary Collection of sociodemographic data of participants At the initial visit, sociodemographic variables will be collected through a Data Collection Notebook (CDR): sex, age, level of education, employment status, civil status. 8 minutes each questionnaire
Primary Collection of clinical data of participants At the initial visit, clinical data will be collected through a Data Collection Notebook (CDR):
Risk factors: Body mass index (BMI), smoking, food consumption
• Weight and height will be combined to report BMI in kg/m^2.
Symptoms throught the questionnaire: The Gastro-oesophageal Reflux Disease Impact Scale (GIS)
Treatments or medications used
8 minutes each questionnaire
Primary Detail the evolution of the patient's symptoms 14 days after intervention An independent external monitor will make a telephone call to each patient to collect the evolution of the patient´s symptoms through a questionnaire: The Gastro-oesophageal Reflux Disease Impact Scale (GIS). It is a scale of frequency, the lower scores mean better health in the patient less frequency of disturbances) 5 minutes
Primary Evaluate patient satisfaction An independent external monitor will make a telephone call to each patient to collect the evolution of the patient´s symptoms through a questionnaire: Degree of satisfaction with the pharmaceutical care received (The score is the level of agreement, high punctuation means more satisfaction) and If the patient gets medication: Treatment Satisfaction Questionnaire for Medication (TSMQ, v1.4). (The score is the level of satisfaction, high punctuation means more satisfaction) 5 minutes
See also
  Status Clinical Trial Phase
Completed NCT01406210 - RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol N/A
Completed NCT01263626 - Cough Monitoring Study N/A
Completed NCT01154634 - Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects Phase 2
Recruiting NCT05629143 - Primary carE PPi dEprescRibing Trial Phase 4
Recruiting NCT05899491 - Role of ARMA in Selective Subset of Refractory GERD Patients. N/A
Active, not recruiting NCT02001727 - HEP-FYN 12-Years Follow-up N/A
Completed NCT00863161 - Renal Impairment Study Phase 1
Active, not recruiting NCT00161096 - On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication Phase 3
Completed NCT00519441 - Do Patients Who Have Had Surgery for Achalasia Suffer From Reflux N/A
Completed NCT00175045 - Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive Esophagitis Phase 2
Terminated NCT04006002 - Mechanism of Weight Loss After Endoscopic and Laparoscopic Sleeve Procedures
Completed NCT02048449 - Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists N/A
Completed NCT00842387 - Evaluation Study of a Management Strategy for Gastroesophageal Reflux Disease (GERD) N/A
Unknown status NCT00216788 - The Effect of Nexium on Transmucosal Esophageal Leak Phase 1
Completed NCT01509352 - Prospective Randomized Trial Evaluating the Utility of Esophageal Stitches During Laparoscopic Fundoplication N/A
Completed NCT04329000 - On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus. N/A
Enrolling by invitation NCT05041608 - Endoscopic Surgery for Gastrointestinal Disorders: A Multicenter Registry Study
Completed NCT02226484 - Can Quercetin Increase Claudin-4 and Improve Esophageal Barrier Function in GERD? Phase 1
Completed NCT00687245 - Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD) Phase 1
Recruiting NCT03418350 - The Role of Laryngopharyngeal Reflux in IPF